SP01
TIM-3/Gal-9 signaling is the molecular target for human myeloid leukemia treatment
Koichi Akashi
Lido
2186
Vezesque se leu este artigo
1121
Total PDF
1065
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 8 | 4 | 12 |
| 2025 5 | 35 | 16 | 51 |
| 2025 4 | 32 | 12 | 44 |
| 2025 3 | 39 | 11 | 50 |
| 2025 2 | 35 | 20 | 55 |
| 2025 1 | 50 | 14 | 64 |
| 2024 12 | 20 | 13 | 33 |
| 2024 11 | 33 | 19 | 52 |
| 2024 10 | 16 | 14 | 30 |
| 2024 9 | 32 | 19 | 51 |
| 2024 8 | 20 | 35 | 55 |
| 2024 7 | 18 | 15 | 33 |
| 2024 6 | 19 | 30 | 49 |
| 2024 5 | 25 | 30 | 55 |
| 2024 4 | 15 | 12 | 27 |
| 2024 3 | 18 | 14 | 32 |
| 2024 2 | 19 | 23 | 42 |
| 2024 1 | 14 | 21 | 35 |
| 2023 12 | 20 | 23 | 43 |
| 2023 11 | 30 | 36 | 66 |
| 2023 10 | 14 | 23 | 37 |
| 2023 9 | 20 | 34 | 54 |
| 2023 8 | 13 | 16 | 29 |
| 2023 7 | 26 | 14 | 40 |
| 2023 6 | 16 | 12 | 28 |
| 2023 5 | 16 | 16 | 32 |
| 2023 4 | 9 | 4 | 13 |
| 2023 3 | 15 | 15 | 30 |
| 2023 2 | 10 | 9 | 19 |
| 2023 1 | 14 | 14 | 28 |
| 2022 12 | 15 | 13 | 28 |
| 2022 11 | 14 | 18 | 32 |
| 2022 10 | 21 | 22 | 43 |
| 2022 9 | 17 | 24 | 41 |
| 2022 8 | 17 | 18 | 35 |
| 2022 7 | 16 | 24 | 40 |
| 2022 6 | 11 | 21 | 32 |
| 2022 5 | 10 | 15 | 25 |
| 2022 4 | 10 | 23 | 33 |
| 2022 3 | 12 | 16 | 28 |
| 2022 2 | 13 | 22 | 35 |
| 2021 1 | 11 | 20 | 31 |
| 2021 12 | 15 | 26 | 41 |
| 2021 11 | 10 | 22 | 32 |
| 2021 10 | 19 | 28 | 47 |
| 2021 9 | 26 | 27 | 53 |
| 2021 8 | 23 | 31 | 54 |
| 2021 7 | 25 | 27 | 52 |
| 2021 6 | 17 | 29 | 46 |
| 2021 5 | 26 | 31 | 57 |
| 2021 4 | 20 | 32 | 52 |
| 2021 3 | 15 | 27 | 42 |
| 2021 2 | 20 | 16 | 36 |
| 2020 1 | 15 | 14 | 29 |
| 2020 12 | 9 | 23 | 32 |
| 2020 11 | 7 | 14 | 21 |
Mostrar tudo
